Does NIVOLUMAB Cause Joint effusion? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Joint effusion have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.0% of all adverse event reports for NIVOLUMAB.
22
Reports of Joint effusion with NIVOLUMAB
0.0%
of all NIVOLUMAB reports
1
Deaths
13
Hospitalizations
How Dangerous Is Joint effusion From NIVOLUMAB?
Of the 22 reports, 1 (4.5%) resulted in death, 13 (59.1%) required hospitalization.
Is Joint effusion Listed in the Official Label?
Yes, Joint effusion is listed as a known adverse reaction in the official FDA drug label for NIVOLUMAB.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Joint effusion?
ADALIMUMAB (1,367)
METHOTREXATE (917)
ETANERCEPT (826)
TOFACITINIB (520)
LEFLUNOMIDE (407)
TOCILIZUMAB (391)
HYDROXYCHLOROQUINE (380)
INFLIXIMAB (372)
RITUXIMAB (368)
PREDNISONE (357)
Which NIVOLUMAB Alternatives Have Lower Joint effusion Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE